ClinicalTrials.Veeva

Menu

Validation of COMPAT-SF Spanish Translation

M

Methodist Health System

Status

Enrolling

Conditions

Chronic Pancreatitis

Treatments

Behavioral: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT06698302
009.GID.2024.D

Details and patient eligibility

About

Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.

Full description

Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older in age
  • Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
  • Able to read and understand the study information in Spanish
  • Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
  • Subject is willing and able to comply with the scheduled questionnaires

Exclusion criteria

  • Subjects who do not meet the criteria in section 4.1

Trial contacts and locations

1

Loading...

Central trial contact

Jeff Wilson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems